Drug companies panic as thirteen “blockbuster” drugs about to lose protection

Reports indicate that the drug industry is in a panic over the patent losses of 13 big-money drugs, and many others, within the next few years. Everyone knows that the drug industry thrives on developing “blockbuster” drugs that reap huge profits during their initial patent period, after which generic competitors can come in and begin producing the same drugs for less. But Big Pharma is having trouble developing new blockbusters to take the places the old blockbusters, which could hit industry profits hard in the very near future. (more…)

FDA shuts down production of non-drug cancer therapy

For several years now I’ve been telling you about the slow-but-sure advances in research of intravenous ascorbic acid (IAA) to treat cancer. And during those years we’ve seen a growing acceptance of the KNOWN FACT that mega-doses of vitamin C effectively kill some types of cancer cells while leaving healthy cells intact.

Imagine what that means! This is potentially a natural, affordable “chemotherapy” that makes patients feel better, rather than reducing their poor bodies to shrunken shells.

Now imagine what that means to Big Pharma and their BFFs at the FDA. (more…)

Were #37

There’s a lot of talk these days about reforming healthcare, and much of this talk is centered around universal health insurance. But the elephant in the room is: no matter who’s paying for the care, our health as a nation isn’t going to improve until we fix the healthcare system.

Americans currently spend $2.4 trillion/year on healthcare. That’s about $4,200 per person. Our nearest competitor, Switzerland, only spends about $2,800 per person. And though we spend far more than anyone, we don’t have the best health. We’re not number two either, nor are we number five, nor ten, nor twenty. In fact according to the World Health Organization, the U.S. ranks 37th in overall health—out of 37 industrialized countries! So we spend the most, but fare the worst. (more…)